PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 20 filers reported holding PROQR THRAPEUTICS N V in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $77,473 | -26.9% | 46,671 | 0.0% | 0.00% | – |
| Q1 2024 | $105,943 | +14.6% | 46,671 | 0.0% | 0.00% | – |
| Q4 2023 | $92,408 | +95.9% | 46,671 | +28.6% | 0.00% | – |
| Q3 2023 | $47,180 | -19.8% | 36,293 | 0.0% | 0.00% | – |
| Q2 2023 | $58,794 | -23.9% | 36,293 | 0.0% | 0.00% | – |
| Q1 2023 | $77,304 | +57589.6% | 36,293 | 0.0% | 0.00% | – |
| Q4 2022 | $134 | -99.5% | 36,293 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | -3.6% | 36,293 | 0.0% | 0.00% | – |
| Q2 2022 | $28,000 | -12.5% | 36,293 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | -89.0% | 36,293 | 0.0% | 0.00% | – |
| Q4 2021 | $290,000 | -4.3% | 36,293 | 0.0% | 0.00% | – |
| Q3 2021 | $303,000 | +77.2% | 36,293 | +42.9% | 0.00% | – |
| Q2 2021 | $171,000 | +32.6% | 25,405 | +30.1% | 0.00% | – |
| Q1 2021 | $129,000 | +130.4% | 19,532 | +45.9% | 0.00% | – |
| Q4 2020 | $56,000 | -80.0% | 13,384 | -77.1% | 0.00% | – |
| Q3 2020 | $280,000 | -16.7% | 58,545 | +5.6% | 0.00% | – |
| Q2 2020 | $336,000 | +13.9% | 55,421 | +2.8% | 0.00% | – |
| Q1 2020 | $295,000 | -71.9% | 53,911 | -49.2% | 0.00% | – |
| Q4 2019 | $1,050,000 | +521.3% | 106,142 | +259.7% | 0.00% | – |
| Q3 2019 | $169,000 | -36.9% | 29,511 | 0.0% | 0.00% | – |
| Q2 2019 | $268,000 | -34.5% | 29,511 | 0.0% | 0.00% | – |
| Q1 2019 | $409,000 | -32.3% | 29,511 | -23.1% | 0.00% | – |
| Q4 2018 | $604,000 | +85.8% | 38,386 | +128.2% | 0.00% | – |
| Q3 2018 | $325,000 | +301.2% | 16,818 | +50.9% | 0.00% | – |
| Q2 2018 | $81,000 | +37.3% | 11,148 | -8.7% | 0.00% | – |
| Q3 2017 | $59,000 | -11.9% | 12,211 | -6.0% | 0.00% | – |
| Q2 2017 | $67,000 | +17.5% | 12,997 | +12.2% | 0.00% | – |
| Q1 2017 | $57,000 | +3.6% | 11,588 | +3.2% | 0.00% | – |
| Q4 2016 | $55,000 | -24.7% | 11,234 | +2.1% | 0.00% | – |
| Q3 2016 | $73,000 | +40.4% | 10,998 | +0.5% | 0.00% | – |
| Q2 2016 | $52,000 | – | 10,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $4,156,000 | 1.38% |
| Prosight Management, LP | 1,707,509 | $1,328,000 | 1.05% |
| Opaleye Management Inc. | 2,740,000 | $2,131,000 | 0.96% |
| M28 Capital Management LP | 1,001,800 | $779,000 | 0.87% |
| Monaco Asset Management SAM | 931,400 | $724,000 | 0.32% |
| APOGEM CAPITAL LLC | 125,273 | $97,000 | 0.09% |
| Ground Swell Capital, LLC | 21,640 | $17,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $117,000 | 0.01% |
| Atom Investors LP | 30,422 | $24,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,300,000 | $2,566,000 | 0.01% |